Clinical Trials Browser

Phase 1/2 × OTHER × tocilizumab × Clear all

NCT04691817 2026-01-07

Tocilizumab and Atezolizumab in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Refractory to 1st Line Immune Checkpoint Inhibitor-Based Therapy

Phase 1/2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT03467256 2023-02-24

CD19 T-CAR for Treatment of Children and Young Adults With r/r B-ALL

Phase 1/2 Unknown

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02997956 2017-04-25

Study of Tocilizumab in Patients With Hepatocellular Carcinoma (HCC) Undergoing Transarterial Chemoembolization (TACE)

Phase 1/2 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular

NCT01637532 2016-01-26

PITCH

Phase 1/2 Completed

Ovarian Neoplasms